EUVIMEDEUVIMED entdecken
Crossref

Pleomorphic Liposarcoma of the Extremity and Trunk: Multimodality Therapy for Some but Not All?

William W Tseng, Francesco Barretta, Francesco Tucci, Marta Barisella, Stefano Radaelli, Chiara Colombo, Dario Callegaro, Carlo Morosi, Roberta Sanfilippo, Chiara Fabbroni, Silvia Stacchiotti, Steven H Sun und 3 weitere

Journal of Surgical Oncology · 2025

DOI: 10.1002/jso.27884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von William W Tseng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology, City of Hope National Medical Center, Duarte, California, USA. Hauptthemen laut MEDLINE: Extremities, Liposarcoma, Neoplasm Recurrence, Local, Torso. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: The authors received no specific funding for this work., Financial support was provided by the Wendy Walk Foundation..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pleomorphic liposarcoma (PLPS) is an ultra‐rare malignancy distinct from well‐differentiated/dedifferentiated and myxoid liposarcoma. In this study, we sought to (1) assess outcomes after surgery for primary, non‐metastatic PLPS and (2) explore potential indications for multimodality therapy.

Methods

Clinicopathologic data were retrospectively collected for patients treated from 2002 to 2019 at our sarcoma referral center. Descriptive data were summarized and Kaplan–Meier plots were constructed for overall survival (OS) and crude cumulative incidences (CCI) of disease‐specific death (DSD), local recurrence (LR), and distant metastasis (DM). Univariable models were performed to assess the association of specific variables of interest on outcome.

Results

Forty‐four pathology‐verified PLPS cases were included in this study. Median tumor size was 8.5 cm; 75% were FNCLCC Grade 3. All patients underwent complete resection, including 15 patients (34%) who required re‐excision to secure microscopic negative margins. Radiation therapy was given to 75% of patients, chemotherapy in 36%. At 5 years, OS was 75.3%; CCI of DSD, LR, and DM were 17.5%, 2.3%, and 32.5%. Larger tumor size was strongly associated with worse OS ( p = 0.028) and DSD ( p ≤ 0.001). A subgroup of patients ( n = 10, 23%) with smaller, predominantly Grade 2 tumors underwent surgery alone without any LR or DM event at a median follow‐up of 7.9 years.

Conclusions

In PLPS, aggressive surgery and when appropriate, radiation therapy, results in excellent local control. Chemotherapy can be considered for larger tumors. Patients with smaller, Grade 2 tumors may be potentially cured with surgery alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExtremitiesLiposarcomaNeoplasm Recurrence, LocalTorsoHumansMaleFemaleMiddle AgedRetrospective StudiesAgedCombined Modality TherapyAdultSurvival RateFollow-Up StudiesAged, 80 and overPrognosis

Stichwörter der Autor:innen

liposarcomapleomorphic liposarcomasoft tissue sarcoma

Autor:innen und Institutionen

  • Department of Surgery, Division of Surgical Oncology, City of Hope National Medical Center, Duarte, California, USA.
  • Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • School of Pathology, University of Milan, Milan, Italy.
  • Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
  • Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Förderung

  • The authors received no specific funding for this work.
  • Financial support was provided by the Wendy Walk Foundation.

Zitieren

APA

Tseng, W. W., Barretta, F., Tucci, F., Barisella, M., Radaelli, S., Colombo, C., Callegaro, D., Morosi, C., Sanfilippo, R., Fabbroni, C., Stacchiotti, S., Sun, S. H., Collini, P., Fiore, M., & Gronchi, A. (2025). Pleomorphic Liposarcoma of the Extremity and Trunk: Multimodality Therapy for Some but Not All?. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27884

Vancouver

Tseng WW, Barretta F, Tucci F, Barisella M, Radaelli S, Colombo C, et al. Pleomorphic Liposarcoma of the Extremity and Trunk: Multimodality Therapy for Some but Not All?. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27884

BibTeX
@article{Tseng2025,
  author = {Tseng, William W and Barretta, Francesco and Tucci, Francesco and Barisella, Marta and Radaelli, Stefano and Colombo, Chiara and Callegaro, Dario and Morosi, Carlo and Sanfilippo, Roberta and Fabbroni, Chiara and Stacchiotti, Silvia and Sun, Steven H and Collini, Paola and Fiore, Marco and Gronchi, Alessandro},
  title = {Pleomorphic Liposarcoma of the Extremity and Trunk: Multimodality Therapy for Some but Not All?},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1002/jso.27884}
}
Kostenlos starten →